,i  #aae? ,,congress  #a/ ,session  ,h4 
,r4 #baac  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,april #bj1 #bjag,mr4 
,/iv]s 7= himself & ,mr4 ,ryan ( ,ohio7 
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce  ,a  
,,bill  ,to require ! ,food & ,drug     
,adm9i/ration to exp$ite review (       
ph>maceuticals t are approv$ = m>ket+ 9 
! ,european ,union4  #a4 ,%ort title    
,?is ,act may be cit$ z ! ,spe$+ ,access
 to ,already ,approv$ ,ph>maceuticals   
,act ( #bjag4  #b4 ,exp$it$ review (    
,,eu-approv$ ph>maceuticals ,section    
#ejf ( ! ,f$]al ,food1 ,drug1 &         
,cosmetic ,act 7#ba ,u4,s4,c4 #cef7 is  
am5d$ by add+ at ! end ! foll[+3  7i7   
,,eu-,approv$ ph>maceuticals  7#a7      
,exp$it$ review ,beg9n+ n lat] ?an #ij  
days aft] a new ph>maceutical is approv$
 = m>ket+ 9 ! ,european ,union1 !       
,secret>y %all1 at ! reque/ ( ! sponsor 
( ! ph>maceutical1 facilitate !         
developm5t & exp$ite ! review ( su* new 
ph>maceutical "u section #eje or #eae ( 

?is ,act or section #cea ( ! ,public    
,heal? ,s]vice ,act1 z appropriate4     
7#b7 ,def9ition ,9 ?is subsection1 ! t]m
 ph>maceutical means a drug 7includ+ a  
biological product7 or a device4  4